STA Pharmaceutical: WuXi STA expands peptide manufacturing capacity to meet global demand

WuXi STA, a prominent global contract research, development and manufacturing organization (CRDMO), has increased its peptide manufacturing output at its Changzhou campus. Located in southern Jiangsu province in China, Changzhou is part of the Yangtze River Delta region, which is among the most economically developed areas in the country. WuXi STA's expansion includes two additional...The post WuXi STA expands peptide manufacturing capacity to meet global demand appeared first on Pharmaceutical Processing World.